Transfusões de concentrados de hemácias pioram os resultados mesmo em pacientes graves, submetidos a estratégia restritiva de transfusão

Autores

  • João Manoel da Silva Junior Hospital do Servidor Público Estadual
  • Ederlon Rezende Hospital do Servidor Público Estadual
  • Cristina Prada Amendola Hospital do Servidor Público Estadual
  • Rafael Tomita Hospital do Servidor Público Estadual
  • Daniele Torres Hospital do Servidor Público Estadual
  • Maria Tereza Ferrari Hospital do Servidor Público Estadual
  • Diogo Oliveira Toledo Hospital do Servidor Público Estadual
  • Amanda Maria Ribas Rosa Oliveira Hospital do Servidor Público Estadual
  • Juliana Andreia Marques Hospital do Servidor Público Estadual

Palavras-chave:

Anemia, Transfusão de sangue, Cuidados intensivos, Mortalidade hospitalar, Morbidade

Resumo

CONTEXTO E OBJETIVO: Anemia e transfusões sanguíneas são comuns em terapia intensiva. O objetivo deste estudo foi investigar a epidemiologia e resultados em pacientes críticos sob o regime de transfusão restritiva. TIPO DE ESTUDO E LOCAL: Estudo de coorte, prospectivo e observacional em unidade de terapia intensiva de um hospital terciário. MÉTODOS: Foram incluídos todos adultos admitidos na unidade durante um ano e que permaneceram internados por mais de 72 horas, exceto pacientes com lesão coronariana aguda, isquemia cerebral aguda, hemorragia aguda, transfusão anterior, mulheres grávidas e testemunhas de Jeová. A estratégia restritiva consiste na transfusão indicada com a hemoglobina inferior ou igual a 7.0 g/dl. RESULTADOS: Totalizando 167 pacientes incluídos, APACHE II (Acute Physiology and Chronic Health disease II) foi de 28,9 ± 6,5. O valor da hemoglobina basal foi de 10,6 ± 2.2 g/dl e no 28o dia foi de 8,2 ± 1.3 g/dl (P < 0,001). 35% dos pacientes receberam transfusões. No grupo de transfusão 61,1% não sobreviveram versus 48,6% do grupo não transfusão (P = 0,03). A transfusão foi fator de risco independente de mortalidade (P = 0,011; odds ratio, OR = 2,67; intervalo de confiança, IC 95% = 1,25-5,69). A internação na unidade de terapia intensiva e hospitalar foi maior no grupo de transfusão: 20,0 (3,0-83,0) versus 8,0 (3,0-63,0) dias (P < 0,001); e 24,0 (3,0-140,0) versus 14,0 (3,0-80,0) dias (P = 0,002). CONCLUSÕES: Em pacientes graves, observou-se redução da hemoglobina com a progressão da permanência na UTI. Além disso, a transfusão foi associada com piores prognósticos.

Downloads

Não há dados estatísticos.

Biografia do Autor

João Manoel da Silva Junior, Hospital do Servidor Público Estadual

MD, MSc. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Ederlon Rezende, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Cristina Prada Amendola, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital de Câncer de Barretos, Fundação Pio XII, Barretos, São Paulo, Brazil.

Rafael Tomita, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Daniele Torres, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Maria Tereza Ferrari, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Diogo Oliveira Toledo, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Amanda Maria Ribas Rosa Oliveira, Hospital do Servidor Público Estadual

MD. Physician, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Juliana Andreia Marques, Hospital do Servidor Público Estadual

MD. Resident, Intensive Care Department, Hospital do Servidor Público Estadual (HSPE), São Paulo, Brazil.

Referências

Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52.

Rodriguez RM, Corwin HL, Gettinger A, et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16(1):36-41.

Levy PS, Chavez RP, Crystal GJ, et al. Oxygen extraction ratio: a valid indicator of transfusion need in limited coronary vascular reserve? J Trauma. 1992;32(6):769-73; discussion 773-4.

Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med. 1994;149(2 Pt 1):533-7.

Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest. 1995;108(3):767-71.

Taylor RW, Manganaro L, O’Brien J, et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30(10):2249-54.

Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055-60.

Hébert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155(5):1618-23.

Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998;279(3):217-21.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29.

Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793-800.

Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-52.

Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med. 1993;21(6):860-6.

Hebert PC, Schweitzer I, Calder L, Blajchman M, Giulivi A. Review of the clinical practice literature on allogeneic red blood cell transfusion. CMAJ. 1997;156(11):S9-S26.

Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499-507.

Silva JM Jr, Cezario TA, Toledo DO, et al. Complications and prognosis of intraoperative blood transfusion. Rev Bras Anestesiol. 2008;58(5):454- 61, 447-54.

Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004;126(1):249-58.

Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105(6):2266-73.

Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-67.

Park KW, Chandhok D. Transfusion-associated complications. Int Anesthesiol Clin. 2004;42(3):11-26.

Robinson WP 3rd, Ahn J, Stiffler A, et al. Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. J Trauma. 2005;58(3):437- 44; discussion 444-5.

Vincent JL, Sakr Y, Sprung C, et al. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely III Patients study. Anesthesiology. 2008;108(1):31-9.

Napolitano LM, Corwin HL. Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin. 2004;20(2):255-68.

Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock. 2004;21(4):291-9.

Spinella PC, Perkins JP, Grathwohl KG, et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med. 2007;35(11):2576-81.

Hébert PC, Tinmouth A, Corwin H. Anemia and red cell transfusion in critically ill patients. Crit Care Med. 2003;31(12 Suppl):S672-7.

Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370(9585):415-26.

Howell PJ, Bamber PA. Severe acute anaemia in a Jehovah’s Witness. Survival without blood transfusion. Anaesthesia. 1987;42(1):44-8.

Sakr Y, Lobo S, Knuepfer S, et al. Anemia and blood transfusion in a surgical intensive care unit. Crit Care. 2010;14(3):R92.

Silva JM Jr, Toledo DO, Magalhães DD, et al. Influence of tissue perfusion on the outcome of surgical patients who need blood transfusion. J Crit Care. 2009;24(3):426-34.

Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth. 1997;44(12):1256-61.

Carson JL, Armas-Loughran B. Blood transfusion: less is more? Crit Care Med. 2003;31(9):2409-10.

Walker RH. Mathematical calculations in transfusion medicine. Clin Lab Med. 1996;16(4):895-906.

Strumia MM, Dugan A, Taylor L, Strumia PV, Bassert D. Splenectomy in leukemia and myelofibrosis. Changes in the erythrocyte values. Am J Clin Pathol. 1962;37:491-8.

Walsh TS, McArdle F, McLellan SA, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med. 2004;32(2):364-71.

Weiskopf RB, Feiner J, Hopf H, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia- induced brain oxygenation deficits in humans. Anesthesiology. 2006;104(5):911-20.

Fergusson D, Khanna MP, Tinmouth A, Hébert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51(5):417-24.

Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev. 2002;16(4):304-14.

Downloads

Publicado

2012-03-03

Como Citar

1.
Silva Junior JM da, Rezende E, Amendola CP, Tomita R, Torres D, Ferrari MT, Toledo DO, Oliveira AMRR, Marques JA. Transfusões de concentrados de hemácias pioram os resultados mesmo em pacientes graves, submetidos a estratégia restritiva de transfusão. Sao Paulo Med J [Internet]. 3º de março de 2012 [citado 14º de março de 2025];130(2):77-83. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/1410

Edição

Seção

Artigo Original